Carlos Almonacid - Concepedia

Author

Carlos Almonacid

Hospital Universitario de Guadalajara ORCID

Also Known As

Borja G. Cosío, C Almonacid, C. Almonacid, Camila Espinoza Almonacid, Carlos Almonacid, Carlos Almonacid Sánchez, Cecilia González Almonacid, J. L. Casado

Publications

855

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario de Guadalajara Universidad de Alcalá Complejo Hospitalario Universitario de Toledo Hospital Universitario Ramón y Cajal Hospital Universitario de La Princesa

About

Carlos Almonacid is an author at Hospital Universitario de Guadalajara specializing in medicine, inflammatory lung disease, and pulmonary medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	289
2	Allergy	2	2	203
3	Allergy Medicine	2	2	203
4	Public Health	1	1	35
5	Emergency Medicine	1	1	39

Carlos Almonacid

Publications

691

Citations

H-Index

Page 1

	Year	Citations
The impact of COVID-19 on patients with asthma José Luís Izquierdo, Carlos Almonacid, Yolanda González, European Respiratory Journal	2020	230
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial Tim Harrison, Pascal Chanez, Francesco Menzella, The Lancet Respiratory Medicine AsthmaSevere Eosinophilic AsthmaAllergyInflammatory Lung DiseaseAllergy Medicine	2020	168
REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma Charles Pilette, Giorgio Walter Canonica, Rekha Chaudhuri, The Journal of Allergy and Clinical Immunology In Practice	2022	94
Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score Luís Pérez de Llano, Ignacio Dávila, Eva Martínez-Moragón, The Journal of Allergy and Clinical Immunology In Practice AsthmaInflammatory Lung DiseaseLung InflammationSymptoms ScoreImmunology	2021	47
Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors José Luís Izquierdo Alonso, Pilar Resano, Abdulkader El Hechem, International Journal of COPD Antifibrotic TherapySurgical OncologyAdvanced Lung DiseaseAirflow ObstructionPrognosis	2014	39
The impact of COVID-19 on patients with asthma José Luís Izquierdo, Carlos Almonacid, Yolanda González, AsthmaArtificial IntelligenceEnvironmental AllergyInflammatory Lung DiseaseLung Inflammation	2020	35
<p>A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future</p> Luis Pérez de Llano, Marc Miravitlles, Rafael Golpe, International Journal of COPD	2020	34
Systemic Corticosteroids in Patients with Bronchial Asthma: A Real-Life Study Carlos Almonacid, Camila Gonçalves de Campos, Diego Morena, Journal of Investigational Allergology and Clinical Immunology	2021	18
Geographical differences in the use of oral corticosteroids in patients with severe asthma in Spain: heat map based on existing databases analyses Carlos Almonacid, Eunice Funenga Fitas, Joaquín Sánchez-Covisa, BMC Pulmonary Medicine	2023	14
Real-life burden of hospitalisations due to COPD exacerbations in Spain José Luís Izquierdo, José Miguel Rodríguez González-Moro, Carlos Almonacid, ERJ Open Research	2022	12

Page 1